22 June 2020: Database Analysis
Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program
Haosheng Wang BCDF , Xueliang Cheng G , Jianwu Zhao F , Mingyang Kang BF , Rongpeng Dong BC , Kai Wang B , Yang Qu AEFG*DOI: 10.12659/MSM.921859
Med Sci Monit 2020; 26:e921859
Table 1 Clinicopathological characteristics of 13,926 patients with papillary renal cell carcinoma (RCC) from the database of the Surveillance, Epidemiology, and End Results (SEER) program.
| Cases evaluated | Number |
|---|---|
| Age, years | |
| ≤40 | 484 (3.48%) |
| 40–49 | 1437 (10.32%) |
| 50–59 | 3389 (24.34%) |
| 60–69 | 4575 (32.85%) |
| 70–79 | 3042 (21.84%) |
| >80 | 799 (7.17%) |
| Gender | |
| Female | 3268 (23.47%) |
| Male | 10658 (76.53%) |
| Race | |
| White | 9707 (69.7%) |
| African-American | 3807 (27.34%) |
| Others | 412 (2.96%) |
| Grade | |
| I | 1400 (10.34%) |
| II | 5902 (42.38%) |
| III | 3533 (25.37%) |
| IV | 434 (3.12%) |
| Unknown | 2617 (18.79%) |
| T | |
| T1 | 10656 (76.52%) |
| T2 | 1511 (10.85%) |
| T3 | 1548 (11.12%) |
| T4 | 98 (0.70%) |
| TX | 113 (0.80%) |
| N | |
| N0 | 13133 (94.31%) |
| N1 | 326 (2.34%) |
| N2 | 241 (1.73%) |
| NX | 226 (1.62%) |
| M | |
| M0 | 13303 (95.53%) |
| M1 | 520 (3.73%) |
| MX | 103 (0.74%) |
| Surgery of primary site | |
| None | 586 (4.48%) |
| Partial nephrectomy | 6245 (47.76%) |
| Total nephrectomy | 6244 (47.776%) |
| Lymphadenectomy, num | |
| 0 | 12697 (91.17%) |
| 1–3 regional lymph nodes | 728 (5.23%) |
| ≥4 regional lymph nodes | 501 (3.60%) |
| Chemotherapy | |
| No/Unknown | 13492 (96.89%) |
| Yes | 434 (3.11%) |
| Marital status | |
| Single | 4763 (34.20%) |
| Married | 9163 (65.80%) |
| SEER – Surveillance, Epidemiology, and End Results; papillary RCC – papillary renal cell carcinoma. | |